Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q3 FY22 results · Oct–Dec 2021
Caplin Point Laboratories reported revenue from operations of ₹326.20 crore and net profit of ₹79.28 crore for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 326.20 | — | — | 303.53 | +7.5% |
| Other income | 9.54 | — | — | 8.49 | +12.4% |
| Total income | 335.74 | — | — | 312.02 | +7.6% |
| Profit before tax | 98.66 | — | — | 97.73 | +1.0% |
| Net profit for the period | 79.28 | — | — | 76.82 | +3.2% |
| Attributable to shareholders of the company | 74.95 | — | — | — | — |
| EPS, basic (₹) | 9.90 | — | — | 9.91 | −0.1% |
| Net margin (%) | 24.3 | — | 25.3 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 128.22 | 123.16 | +4.1% | 160.40 | −20.1% |
| Other income | 8.54 | 3.98 | +114.6% | 18.42 | −53.6% |
| Total income | 136.76 | 127.14 | +7.6% | 178.82 | −23.5% |
| Profit before tax | 55.69 | 55.31 | +0.7% | 83.49 | −33.3% |
| Net profit for the period | 39.12 | 41.48 | −5.7% | 65.16 | −40.0% |
| EPS, basic (₹) | 5.17 | 5.48 | −5.7% | 8.61 | −40.0% |
| Net margin (%) | 30.5 | 33.7 | 40.6 |
Consolidated
- Filed with BSE
- 04 Feb 2022, 13:42 IST
- Board meeting
- 03 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2022, 13:42 IST
- Board meeting
- 03 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE